SELL and AVOID IMVHO29 Nov 2012 17:03
So CWR have finally announced their fund raising and again proven me right with my views that the 10p+ per share ramping on CWR BB's was never going to happen. As I correctly stated, CWR is only worth what anyone with the cash is willing to pay for the stock, which it transpires is ONE PENNY PER SHARE! (way below even my conservative estimate that they might get cash at 3p-4p)
They are 'hoping' for this "Proposed Firm Placing to raise £2,650,000 and Placing and Open Offer to raise £650,000 to raise a total of £3,300,000 (before expenses)". They might get the placing cash as it's easy for voters to say yes to the free money, but the extra £650k of existing investors cash, I doubt they will even get 1/3 of it.
"Issue price for the Firm Placing and Placing and Open Offer of 1 pence per New Ordinary Share"
Note "the Board is proposing to raise £3.30 million (before expenses) through the issue of 265,000,000 New Ordinary Shares through a Firm Placing and 65,000,000 New Ordinary Shares through a Placing and Open Offer"
Currently there are 86,215,662 shares in issue. After the fund raising, if it goes through:
265,000,000 + 65,000,000 + 86,215,662 = 177,715,662 x 1p per share = £4,162,156.62 MCap
Some people were claiming CWR was worth £10m+ with a much smaller placing at 10p a share LOL!!!!
Today the stock is well over valued at £2.56m MCAP. It will fall as the placing date gets closer because the current stock after dilution will only be worth 1p per share for £862,156.62 IN TOTAL vs the £2.56m it is currently priced at.
The new business plan changes very little, all it does is remove the big overheads of an overweight company and spilt future potential from mCHP with partner companies, greatly reducing potential future earnings from what longs were anticipating. What it certainly does not do is bring sales any closer than 2016, because CWR can make stacks but they still need to progress them to a commercially viable state, then the partners have to test them for extended periods to PROVE that the systems are commercially viable. The time-scale CWR had of 2016 won't be altered by the change of business plan.
"The Ceres development plan through to the next field trials in 2014 and the anticipated product launch in 2016, requires further testing and refinement of its core technology and validation of degradation and cycling on multiple stacks over extended periods of operation. "
http://www.investegate.co.uk/ceres-power-holdings-(cwr)/rns/technology-update-and-independent-expert-report/201209180700044291M/
The risk to investors of a failed second attempt to prove the technology can produce a VIABLE commercial product, is no less in the new plan than under the old plan.
The stock is still a SELL and AVOID IMVHO